Skip to content

Apotheek Pharmalies

Active Risk: not assessed
Private limited company (pre-2019)founded 2008active for 18 yearsKortrijksesteenweg 580, 9000 Gent, BelgiumKBO/BCE: BE 0899.741.415

From the official registers: KBO 17 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Pharmalies is a financial institution. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €285,259 and a net result of €16,236. Equity has been shrinking by about 5.8% per year since 2018. Its solvency ranks better than 61% of 9,750 sector peers (NACE 64, financial year 2025). The company has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

KBO
Status
Active since 11-08-2008 Normal situation
Activity
Activities of holding companies NACE 64210
Establishment unit
2.181.662.236 9000 Gent, since 04-08-2008
Financial year end
31 December
Peppol
Reachable since 21-10-2026

Financial position

Financial institution: outside the modelBankruptcy probability: sector outside the model
Annual accounts 2025
Profit
€16,236
▼ 40.9%
Equity
€285,259
▲ 6.0%
Total assets
€449,305
▲ 4.2%
Filed on 29-09-2026, 60 days after the deadlineat the National Bank
Signalsraises risk2025 accounts filed 60 days latelowers riskGrowing equityShow the evidence

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Two signals.
lowers riskraises risk
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €285,259
raises risk · 2025 accounts filed 60 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-09-2026, 60 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
60 days late
2024
22 days late
2023
57 days late
2022
64 days late
2021
82 days late
2020
31 days late
2019
98 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 59 days after the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Comparable companies

These companies have the same main activity as Apotheek Pharmalies: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €397,000 and €498,000, founded between 2007 and 2010.

CompanyTotal assetsGross margin
Apotheek Pharmalies Gent€449,305€41,834
DASTO Kruisem€498,441€40,203
De Poorterstuin Buggenhout€411,580€41,111
CANDELLERO Gent€414,721€39,795
HEIDI BRUGGEMAN Eeklo€469,598€39,700
GLASS ENGINEERING AND MANAGEMENT Oudenaarde€495,638€50,915
GEELIN Hamme (Vl.)€396,634€34,837
Full comparison

Documents

Annual accounts at the NBB

All 17 annual accounts

Articles and registers

Key facts about Apotheek Pharmalies

What is the company number of Apotheek Pharmalies?
The company number of Apotheek Pharmalies is 0899.741.415. The VAT number is the same number with BE in front: BE 0899.741.415.
Where is Apotheek Pharmalies based?
The registered office is at Kortrijksesteenweg 580, 9000 Gent.Company details
What does Apotheek Pharmalies do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of Apotheek Pharmalies?
The legal form of Apotheek Pharmalies is Private limited company (pre-2019) (BVBA).
When was Apotheek Pharmalies founded?
Apotheek Pharmalies was founded on 11-08-2008.
Is Apotheek Pharmalies still active?
Yes, Apotheek Pharmalies is an active enterprise in the KBO register.
What is the turnover of Apotheek Pharmalies?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €41,834 and 2,949 comparable companies of the same size. It probably lies between €100,000 and €300,000. It is a rough estimate.Financials
Is Apotheek Pharmalies profitable?
In financial year 2025, Apotheek Pharmalies made a profit of €16,236.
Where can I find the annual accounts of Apotheek Pharmalies?
Apotheek Pharmalies filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Apotheek Pharmalies due?
Apotheek Pharmalies must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.